Health

Genetic testing company 23andMe's bankruptcy has led to a new consumer privacy issue: what happens to the DNA of millions of Americans when it goes on sale?

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease. 

The Food and Drug Administration's top vaccine regulator Peter Marks has resigned, citing Sec. Robert F. Kennedy Jr.'s "misinformation and lies" around immunization.

We're making a couple of small buys to take advantage of Friday's lower prices.

The massive cuts at Robert F. Kennedy Jr.'s Health and Human Services Department could affect teams that respond to outbreaks and help with insurance coverage.

Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on immunotherapy.

23andMe co-founder Linda Avey expressed frustration about the fall of the genetic testing company in a social media post.

Dr. Vin Gupta, a high-profile public health expert and clinician, has left Amazon after five years at the company.

Now that 23andMe has filed for bankruptcy, another company could take control of its genetic database.

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors' perception of the health care system is improving.